Zomedica Secures CE Mark for TRUVIEWTM Digital Microscope and Telepathology System, Expanding Global Market Opportunities Page 1

CE mark opens European market for TRUVIEW system

ANN ARBOR, MI / ACCESSWIRE / September 5, 2024 / Zomedica Corp. (NYSE American:ZOM) (“Zomedica” or the “Company”), a veterinary health company providing point-of-care diagnostics and therapeutic products for horses and companion animals, today announced that it has received CE Mark approval for its revolutionary TRUVIEW digital microscopy and telepathology platform. The CE Mark certifies that the system meets the stringent health, safety and environmental standards required by the European Union, allowing Zomedica to commercialize the TRUVIEW microscope throughout the European Economic Area (EEA).

The TRUVIEW platform integrates advanced diagnostic features including LiquiView liquid lens technology for superior imaging and the patented TRUprep system for automated slide preparation. This all-in-one solution provides veterinary professionals with advanced capabilities that improve both diagnostic accuracy and efficiency.